Entries of Gajewski, Thomas F. on the publication server

Chesney, Jason A., Ribas, Antoni, Long, Georgina V. , Kirkwood, John M. , Dummer, Reinhard, Puzanov, Igor , Hoeller, Christoph, Gajewski, Thomas F., Gutzmer, Ralf, Rutkowski, Piotr , Demidov, Lev, Arenberger, Petr, Shin, Sang Joon, Ferrucci, Pier Francesco, Haydon, Andrew, Hyngstrom, John, van Thienen, Johannes V., Haferkamp, Sebastian , Guilera, Josep Malvehy, Rapoport, Bernardo Leon , VanderWalde, Ari, Diede, Scott J. , Anderson, James R., Treichel, Sheryl, Chan, Edward L., Bhatta, Sumita, Gansert, Jennifer, Hodi, Frank Stephen and Gogas, Helen (2023) Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. Journal of Clinical Oncology 41 (3), pp. 528-540. Fulltext not available.

Schuster, Kerstin, Gadiot, Jules, Andreesen, Reinhard, Mackensen, Andreas, Gajewski, Thomas F. and Blank, Christian (2009) Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L‐selectin‐mediated homing to peripheral LN. European Journal of Immunology 39 (11), pp. 2981-2990. Fulltext not available.

Blank, Christian, Kuball, Juergen, Voelkl, Simon, Wiendl, Heinz , Becker, Bernd, Walter, Bernhard, Majdic, Otto, Gajewski, Thomas F., Theobald, Mathias, Andreesen, Reinhard and Mackensen, Andreas (2006) Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. International journal of cancer. Journal international du cancer 119 (2), pp. 317-327. Fulltext restricted.

Blank, Christian, Gajewski, Thomas F. and Mackensen, Andreas (2005) Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunology, Immunotherapy 54 (4), pp. 307-314. Fulltext not available.